Coloplast A/S (OTCMKTS:CLPBY) Sees Unusually-High Trading Volume – Should You Buy?

Posted by Scott Moore on Mar 22nd, 2026

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) saw an uptick in trading volume on Friday . 1,164,778 shares traded hands during mid-day trading, an increase of 161% from the previous session’s volume of 445,557 shares.The stock last traded at $6.62 and had previously closed at $6.6650.

Wall Street Analysts Forecast Growth

Separately, Sanford C. Bernstein raised shares of Coloplast A/S to a “hold” rating in a report on Wednesday, January 28th. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.

View Our Latest Analysis on Coloplast A/S

Coloplast A/S Stock Performance

The company has a current ratio of 1.30, a quick ratio of 0.81 and a debt-to-equity ratio of 1.50. The stock’s 50 day moving average is $7.85 and its 200 day moving average is $8.62. The stock has a market capitalization of $14.83 billion, a price-to-earnings ratio of 24.37, a PEG ratio of 0.66 and a beta of 0.33.

Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last announced its quarterly earnings results on Friday, February 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.01. The company had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.12 billion. Coloplast A/S had a net margin of 14.35% and a return on equity of 27.87%. On average, analysts predict that Coloplast A/S Sponsored ADR will post 0.31 earnings per share for the current year.

Coloplast A/S Company Profile

(Get Free Report)

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.